Antimitotic Agents: all 5,052 studies that test it

Page 48 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00008333Phase 2
• Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00008125Phase 1
• Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the EsophagusStatus unknownNCT00008047Phase 1/2
• Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's LymphomaStatus unknownNCT00008021Phase 1
• Adjuvant Stage 2-3A Breast Cancer With Positive Lymph NodesCompletedNCT00007904Phase 2
• Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00006929Phase 2
• Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00006760Phase 2
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorCompletedNCT00006734Phase 3
• Vinorelbine and Docetaxel in Treating Women With Metastatic Breast CancerCompletedNCT00006682Phase 2
• Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00006484Phase 3
• Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal CancerTerminatedNCT00006472Phase 2
• Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00006469Phase 2
• Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal TumorCompletedNCT00006461Phase 3
• Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast CancerCompletedNCT00006459Phase 3
• Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial CancerCompletedNCT00006454Phase 3
• Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's LymphomaCompletedNCT00006383Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00006378Phase 2
• Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00006377Phase 2
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerWithdrawnNCT00006374Phase 2
• Micellar Paclitaxel to Treat Severe PsoriasisCompletedNCT00006276Phase 2
• SU5416 and Paclitaxel in Treating Patients With Advanced CancerCompletedNCT00006257Phase 1
• Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast CancerCompletedNCT00006256Phase 2
• S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00006248Phase 2
• Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous PaclitaxelCompletedNCT00006245Phase 2
• BMS-247550 in Treating Patients With Advanced CancersCompletedNCT00006221Phase 1
• Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00006215Phase 2
• Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast CancerStatus unknownNCT00006120Phase 2
• Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder CancerStatus unknownNCT00006118Phase 2
• Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00006108Phase 1/2
• Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00006107Phase 1
• Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00006104Phase 2
• Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00006095Phase 1
• Vinorelbine in Treating Patients With Metastatic or Advanced Solid TumorsStatus unknownNCT00006088Phase 1
• BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic CancerCompletedNCT00006086Phase 1
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerCompletedNCT00006081Phase 2
• ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00006049Phase 3
• Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerCompletedNCT00006038Phase 2
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00006029Phase 1/2
• Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNCT00006018Phase 1
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00006012Phase 1/2
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver CancerCompletedNCT00006010Phase 2
• Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung CancerCompletedNCT00006004Phase 2
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00005964Phase 2
• Docetaxel and Carboplatin in Treating Women With Metastatic Breast CancerCompletedNCT00005963Phase 2
• Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005960Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerStatus unknownNCT00005958Phase 2
• Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung CancerCompletedNCT00005868Phase 2
• Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00005865Phase 2
• Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone TherapyCompletedNCT00005857Phase 2
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNCT00005849Phase 2
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005847Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00005840Phase 1
• Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerCompletedNCT00005831Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00005819Phase 1
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005810Phase 2
• Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian CancerCompletedNCT00005807Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00005806Phase 1
• Doxorubicin and Docetaxel in Treating Women With Stage III Breast CancerCompletedNCT00005800Phase 2
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS TumorsCompletedNCT00005796Phase 1
• Paclitaxel and Capecitabine in Treating Women With Metastatic Breast CancerCompletedNCT00005649Phase 2
• SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckCompletedNCT00005647Phase 1
• Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00005646Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionCompletedNCT00005644Phase 2
• Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00005635Phase 2
• Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005627Phase 1
• BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TreatmentStatus unknownNCT00005611Phase 1
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00005599Phase 2
• Combination Chemotherapy in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00005581Phase 3
• Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic LeukemiaCompletedNCT00005579Phase 2
• Docetaxel in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00005096Phase 2
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck CancerCompletedNCT00005087Phase 2
• Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder CancerCompletedNCT00005086Phase 2
• Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid TumorsCompletedNCT00005078Phase 1
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00005065Phase 1
• Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung CancerCompletedNCT00005059Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial CancerCompletedNCT00005051Phase 2
• Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005048Phase 1
• Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal CancerCompletedNCT00005046Phase 1
• Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00005032Phase 1/2
• Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerCompletedNCT00005028Phase 2
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00005026Phase 1
• Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or LymphomaCompletedNCT00005021Phase 1
• Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid TumorsCompletedNCT00004979Phase 1/2
• Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerCompletedNCT00004934Phase 3
• BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004927Phase 1
• Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00004924Phase 2
• Docetaxel and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00004923Phase 1/2
• Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00004916Phase 1/2
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00004913Phase 1
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerCompletedNCT00004906Phase 2
• Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00004887Phase 3
• MS 209 Plus Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00004886Phase 1
• Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00004884Phase 2
• Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00004864Phase 1
• Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00004863Phase 1
• Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary CirrhosisCompletedNCT00004748Phase 3
• Phase I Study of Colchicine Therapy in Childhood Hepatic CirrhosisStatus unknownNCT00004368Phase 1
• Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung CancerStatus unknownNCT00004265Phase 2
• Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT00004264Phase 1/2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00004253Phase 2

← Antimitotic Agents overview